Day: November 6, 2019

Extra bolagsstämma i Oasmia Pharmaceutical AB den 6 november 2019

Written by Customer Service on November 6, 2019. Posted in Public Companies.

Oasmia Pharmaceutical AB (publ) höll under onsdagen den 6 november 2019 en extra bolagsstämma. Stämman beslutade i enlighet med styrelsens förslag att styrelsen får i bemyndigande att intill nästa årsstämma vid ett eller flera tillfällen besluta om nyemission av aktier, inom bolagsordningens gränser, med företrädesrätt för befintliga aktieägare att betalas kontant, genom apport och/eller genom kvittning.Syftet med bemyndigandet är att likviden från företrädesemissionen huvudsakligen ska användas för att finansiera och accelerera kommersialiseringen av Apealea samt tillvarata nya affärsmöjligheter baserade på Bolagets unika XR17-plattform. Därutöver avser Oasmia att skapa en stabil finansiell position för Bolaget som möjliggör en expansion inom nya områden samt ett stabilt flöde av nya projekt.Utgivande av nya aktier med stöd av bemyndigandet...

VALOE INTERIM REPORT 1 JANUARY – 30 SEPTEMBER

Written by Customer Service on November 6, 2019. Posted in Earnings Releases And Operating Results.

Valoe Corporation Interim Report 6 November 2019VALOE INTERIM REPORT 1 JANUARY – 30 SEPTEMBER 2019 SUMMARY– Valoe Corporation (“Valoe”) disclosed on 24 September 2019 that the company has resolved on a directed share issue in order to cover the working capital needs of the company, to finance the strategic investments of the company and to improve the financial performance of the company. Further, on 24 September 2019, the company published the prospectus of Valoe pursuant to the Securities Market Act regarding the offering of new shares in the company and admission to trading at Nasdaq Helsinki Oy. In total 79,403,553 new shares were acceptably subscribed in the offering. The subscription price for in total 38,337,744 of the new shares subscribed...

VALOE OYJ:N OSAVUOSIKATSAUS 1.1.2019 – 30.9.2019

Written by Customer Service on November 6, 2019. Posted in Earnings Releases And Operating Results.

Valoe Oyj Osavuosikatsaus 6.11.2019VALOE OYJ:N OSAVUOSIKATSAUS 1.1.2019 – 30.9.2019YHTEENVETOValoe tiedotti 24.9.2019 päättäneensä osakeannista, jonka tavoitteena oli kerätä rahoitusta yhtiön käyttöpääomavajauksen kattamiseksi, yhtiön strategisten investointien mm. IBC-kennoteknologiaan rahoittamiseksi ja yhtiön pääomarakenteen vahvistamiseksi. Lisäksi yhtiö julkaisi 24.9.2019 arvopaperimarkkinalain mukaisen esitteen uusien osakkeiden tarjoamiseen ja listalleottoon Nasdaq Helsinki Oy:n pörssilistalle. Osakeannissa merkittiin hyväksytysti yhteensä 79.403.553 uutta osaketta. Osakeannissa merkityistä uusista osakkeista yhteensä 38.337.744 uuden osakkeen merkintähinta maksettiin rahana ja yhteensä 41.065.809 uuden osakkeen merkintähinta maksettiin kuittaamalla...

Sophos Group plc Interim results for the six-month period-ended 30 September 2019

Written by Customer Service on November 6, 2019. Posted in Earnings Releases And Operating Results.

Revenue growth of 8% and Billings growth of 9% at constant currency (“CC”) year-on-year (“YOY”); Progress in next-gen transition and growth in Sophos CentralOXFORD, United Kingdom, Nov. 06, 2019 (GLOBE NEWSWIRE) — Sophos Group plc (the “Group” / LSE: SOPH), a leading provider of next-generation cloud-enabled enduser and network cybersecurity solutions, today issues its interim results for the six-months to 30 September 2019 (“H1 FY20”).Financial highlightsReported Group revenue of $365.8 million grew 5% YOY (+8% CC) – Subscription revenue remained the principal driver of YOY growth, increasing by 8% (+11% CC), and offsetting an 8% reduction in revenue from hardware (-5% CC)Reported Group billings(1) of $372.0 million increased by 5% YOY (+9% CC) – Next-gen(2) billings grew...

Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2019 Financial Results

Written by Customer Service on November 6, 2019. Posted in Earnings Releases And Operating Results.

First MANIFEST data showing signs of CPI-0610 clinical activity in JAK-inhibitor-naïve myelofibrosis patientsData showing signs of continuing activity in ruxolitinib-refractory or -intolerant patientsExpanded MANIFEST to enroll more JAK-inhibitor-naïve patients and transfusion-dependent ruxolitinib-refractory or -intolerant patientsMANIFEST oral presentation, poster, and investor event scheduled for December 9 at ASHRandomized Phase 3 clinical trial of CPI-0610 in first-line setting expected to start in 2020Significant additional progress being made across the Company’s portfolio CAMBRIDGE, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced its third-quarter and...

Wayside Technology Group, Inc. Reports 2019 Third Quarter Results and Declares Quarterly Dividend

Written by Customer Service on November 6, 2019. Posted in Dividend Reports And Estimates.

EATONTOWN, N.J., Nov. 06, 2019 (GLOBE NEWSWIRE) — Wayside Technology Group, Inc. (NASDAQ: WSTG) today announced financial results for the third quarter ended September 30, 2019. The results will be discussed in a conference call to be held on Wednesday, November 6, 2019 at 10:00 a.m. EST. The dial-in telephone number is (844) 683-0552 and the pass code is “WSTG.” This conference call will be webcast by West and can be accessed at Wayside Technology’s website at www.waysidetechnology.com/site/content/webcasts.“We are pleased to report our second consecutive quarter of double digit growth in gross profit,” said Michael Vesey, Vice President and Chief Financial Officer. “This growth continues to be driven by our core strategy of investing in sustainable growth opportunities in our Lifeboat distribution business. The results demonstrate...

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares

Written by Customer Service on November 6, 2019. Posted in Dividend Reports And Estimates.

JERSEY CITY, N.J., Nov. 06, 2019 (GLOBE NEWSWIRE) — BEL FUSE INC. (NASDAQ:BELFA) and (NASDAQ:BELFB) today announced that its Board of Directors has declared regular quarterly cash dividends of $0.06 per share on the Company’s Class A common shares and $0.07 per share on the Company’s Class B common shares.Cash dividends for Class A and Class B common shares are payable on January 31, 2020 to shareholders of record on January 15, 2020.Bel currently has approximately 12,274,000 common shares outstanding, of which 2,145,000 are Class A common shares and 10,129,000 are Class B common shares.About BelBel (www.belfuse.com) designs, manufactures and markets a broad array of products that power, protect and connect electronic circuits. These products are primarily used in the networking, telecommunications, computing, military,...

AAON Announces Semi-Annual Cash Dividend

Written by Customer Service on November 6, 2019. Posted in Dividend Reports And Estimates.

TULSA, Okla., Nov. 06, 2019 (GLOBE NEWSWIRE) — AAON, Inc. (NASDAQ: AAON), today announced that its Board of Directors has declared its next regular semi-annual cash dividend of $0.16 per share or $0.32 annually. The next cash dividend will be payable on December 18, 2019, to stockholders of record as of the close of business on November 27, 2019.About AAONAAON is engaged in the engineering, manufacturing, marketing and sale of air conditioning and heating equipment consisting of standard, semi-custom and custom rooftop units, chillers, packaged outdoor mechanical rooms, air handling units, condensing units, makeup air units, energy recovery units, geothermal/water-source heat pumps, coils, and controls. Since the founding of AAON in 1988, AAON has maintained a commitment to design, develop, manufacture and deliver heating and cooling...

Barrick Announces Increased Dividend for Q3 2019

Written by Customer Service on November 6, 2019. Posted in Dividend Reports And Estimates.

All amounts expressed in US dollarsLONDON, Nov. 06, 2019 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) today announced that its Board of Directors has declared a dividend for the third quarter of 2019 of $0.05 per share, a 25% increase on the previous quarter’s dividend, payable on December 16, 2019 to shareholders of record at the close of business on November 29, 2019.1Senior Executive Vice-President and Chief Financial Officer Graham Shuttleworth said Barrick’s business continued to perform well and the increased dividend reflected its strong operating performance and growth in cashflows, and is consistent with the Company’s stated financial and operating objectives.Enquiries:Website: www.barrick.com1 The declaration and payment of dividends is at the discretion of the Board of Directors, and will depend on...

Brookfield Property REIT Inc. Declares Quarterly Dividends

Written by Customer Service on November 6, 2019. Posted in Dividend Reports And Estimates.

BROOKFIELD NEWS, Nov. 06, 2019 (GLOBE NEWSWIRE) — Brookfield Property REIT Inc. (NASDAQ: BPR) announced today that its Board of Directors has declared a quarterly dividend of $0.33 per share payable on December 31, 2019 to shareholders of record at the close of business on November 29, 2019.The Board of Directors has also declared a quarterly dividend on the 6.375% Series A Cumulative Redeemable Preferred Stock (NASDAQ: BPRAP) of $0.3984375 per share payable on January 1, 2020, to stockholders of record on December 13, 2019.About Brookfield Property REIT Inc.Brookfield Property REIT Inc. (“BPR”) is a subsidiary of Brookfield Property Partners L.P. (NASDAQ: BPY; TSX: BPY.UN) (“BPY”), one of the world’s largest commercial real estate companies, with over $85 billion in total assets. BPR was created as a public security that is intended...

Day: November 6, 2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals